|
|
| Line 1: |
Line 1: |
| − | <div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output">__NOTOC__Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map]] or [[ZOOM_MAP_-_Expand_Harm_Reduction_Practices_Associated_with_Opioid_Misuse|Zoom Map (Expand Harm Reduction Practices Associated with Opioid Misuse)]] <div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block">__TOC__ | + | <parsererror xmlns="http://www.mozilla.org/newlayout/xml/parsererror.xml">XML Parsing Error: syntax error</parsererror> |
| − | = Current Status =
| |
| − | | |
| − | *Hep C virus (HCV) infections tripled between 2010 and 2015
| |
| − | *Substance abuse and infectious diseases shared common populations, risk factors, social determinants, and even contracting venues<sup class="reference">[1]</sup>
| |
| − | *There was little collaboration between programs that provided services to these populations<sup class="reference">[2]</sup>
| |
| − | *Methadone clinics would be optimal venues for service integration because these clinics serve a population that is 60% injection drug users; have medical staff performing brief health assessments for all new clients; and already have some infectious disease screenings in place, including routine tuberculosis testing and intermittent opt-in HIV testing<sup class="reference">[3]</sup>
| |
| − | *One study showed that 68% of opioid treatment programs nationwide had staff capacity for HCV testing, but only 33% actually offered on-site HCV testing<sup class="reference">[4]</sup>
| |
| − | *<span style="background-color: #ffffff; color: #333333; font-family: Roboto,'Helvetica Neue',Helvetica,Arial,sans-serif; font-size: 16px">Awareness of HCV infection among this particular population may motivate them to reduce their consumption and hopefully high-risk behavior</span><br/>
| |
| − | | |
| − | = Barriers to Access =
| |
| − | | |
| − |
| |
| − | | |
| − | = Promising Programs =
| |
| − | | |
| − | == Texas Department of State Health Services ==
| |
| − | | |
| − | [https://www.cdc.gov/nchhstp/programintegration/successstories-tx/inf-disease-screening.html [1]]<br/>
| |
| − | | |
| − | == Philly Website ==
| |
| − | | |
| − | [http://www.phillyhepatitis.org/support-care/ phillyhepatits.org] is an example of a resource for people seeking to identify if they have hepatitis, next steps they can take, and where they can find care or assistance.<br/>
| |
| − | | |
| − | == TLC Awareness Campaign ==
| |
| − | | |
| − | [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342624/ "Test, Listen, Cure" (TLC) Hepatitis C Community Awareness Campaign] provides information about how HCV infection is transmitted, risk factors for the disease, the importance of screening and treatment, and the availability of improved treatment for the disease.
| |
| − | | |
| − | = Tools & Resources =
| |
| − | | |
| − | [[TR_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|TR - Improve Screening for Infectious Disease among Opioid Users]]
| |
| − | | |
| − | = Scorecard Building =
| |
| − | | |
| − | [[PO_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|Potential Objective Details]]<br/> [[PM_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|Potential Measures and Data Sources]]<br/> [[PA_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|Potential Actions and Partners]]
| |
| − | | |
| − | = Resources to Investigate =
| |
| − | | |
| − | [[RTI_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|More RTI ]][[RTI_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|on]][[RTI_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|Improve Screening for Infectious Disease among Opioid Users]]<br/> <br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">PAGE MANAGER</span>:''' </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[insert name here]</span><br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">SUBJECT MATTER EXPERT</span>''': </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[fill out table below]</span>
| |
| − | | |
| − | {| class="wiki_table"
| |
| − | |-
| |
| − | | '''Reviewer'''
| |
| − | | '''Date'''
| |
| − | | '''Comments'''
| |
| − | |-
| |
| − | |
| |
| − | |
| |
| − | |
| |
| − | |}
| |
| − | | |
| − | = Sources =
| |
| − | | |
| − | ----
| |
| − | | |
| − | #[https://www.cdc.gov/nchhstp/programintegration/successstories-tx/inf-disease-screening.html [2]]
| |
| − | #[https://www.cdc.gov/nchhstp/programintegration/successstories-tx/inf-disease-screening.html [3]]
| |
| − | #[https://www.cdc.gov/nchhstp/programintegration/successstories-tx/inf-disease-screening.html [4]]
| |
| − | ##
| |
| − | ##*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670662/ [5]]
| |
| − | </div> </div> </div> </div> </div> </div> </div> </div> </div>
| |
| − | [[Category:SAFE-Prescriptions and Medical Response]]
| |
